Cargando…

The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models

Background. Glioblastoma multiforme (GBM) is a devastating disease showing a very poor prognosis. New therapeutic approaches are needed to improve survival and quality of life. GBM is a highly vascularized tumor and as such, chemotherapy and anti-angiogenic drugs have been combined for treatment. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gravina, Giovanni Luca, Mancini, Andrea, Colapietro, Alessandro, Delle Monache, Simona, Sferra, Roberta, Pompili, Simona, Vitale, Flora, Martellucci, Stefano, Marampon, Francesco, Mattei, Vincenzo, Biordi, Leda, Sherris, David, Festuccia, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826425/ https://www.ncbi.nlm.nih.gov/pubmed/31640252 http://dx.doi.org/10.3390/cancers11101604

Ejemplares similares

Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma
por: Colapietro, Alessandro, et al.
Publicado: (2021)

The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
por: Gravina, Giovanni Luca, et al.
Publicado: (2019)

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
por: Gravina, Giovanni Luca, et al.
Publicado: (2017)

Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
por: Gravina, Giovanni Luca, et al.
Publicado: (2017)

Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
por: Gravina, Giovanni Luca, et al.
Publicado: (2019)

ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma
por: Gravina, Giovanni Luca, et al.
Publicado: (2022)

The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
por: Mattei, Vincenzo, et al.
Publicado: (2021)

The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
por: Festuccia, Claudio, et al.
Publicado: (2018)

The Botanical Drug PBI-05204, a Supercritical CO(2) Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties
por: Colapietro, Alessandro, et al.
Publicado: (2020)

Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth
por: Festuccia, Claudio, et al.
Publicado: (2019)

RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
por: Weinberg, Mark A.
Publicado: (2016)

Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
por: Festuccia, C., et al.
Publicado: (2018)

Regulation of adiposity by mTORC1
por: Magdalon, Juliana, et al.
Publicado: (2017)

The Botanical Drug PBI-05204, a Supercritical CO(2) Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma
por: Colapietro, Alessandro, et al.
Publicado: (2022)

Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage
por: Marampon, Francesco, et al.
Publicado: (2015)

Correction: Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage
por: Marampon, Francesco, et al.
Publicado: (2016)

Regenerative Potential of DPSCs and Revascularization: Direct, Paracrine or Autocrine Effect?
por: Mattei, Vincenzo, et al.
Publicado: (2021)

The possible prognostic role of histone deacetylase and transforming growth factor β/ Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study
por: Sferra, Roberta, et al.
Publicado: (2017)

Crocetin Extracted from Saffron Shows Antitumor Effects in Models of Human Glioblastoma
por: Colapietro, Alessandro, et al.
Publicado: (2020)

UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice
por: Festuccia, Claudio, et al.
Publicado: (2018)

Dental Pulp Stem Cells (DPSCs) and Tissue Regeneration: Mechanisms Mediated by Direct, Paracrine, or Autocrine Effects
por: Mattei, Vincenzo, et al.
Publicado: (2023)

10th Anniversary of Biomedicines—Advances in Mesenchymal Stem Cells
por: Mattei, Vincenzo, et al.
Publicado: (2023)

Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB
por: Hsu, Ming-Jen, et al.
Publicado: (2022)

Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models
por: Gravina, Giovanni Luca, et al.
Publicado: (2017)

Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps?
por: Vetuschi, Antonella, et al.
Publicado: (2020)

Regulation of Autophagy through TORC1 and mTORC1
por: Noda, Takeshi
Publicado: (2017)

Cellular and Molecular Mechanisms Mediated by recPrP(C) Involved in the Neuronal Differentiation Process of Mesenchymal Stem Cells
por: Martellucci, Stefano, et al.
Publicado: (2019)

Hypoxia Induces DPSC Differentiation versus a Neurogenic Phenotype by the Paracrine Mechanism
por: Delle Monache, Simona, et al.
Publicado: (2022)

mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)

The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer
por: Diaz, R, et al.
Publicado: (2009)

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
por: Martini, Maurizio, et al.
Publicado: (2018)

The hammer of TORC1!
por: Dufour, Eric
Publicado: (2015)

Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR(ser81) and CDK1 signaling: biological implications for men treated with testosterone replacement therapy
por: Gravina, Giovanni Luca, et al.
Publicado: (2017)

TORC1 Organised in Inhibited Domains (TOROIDs) regulate TORC1 activity
por: Prouteau, Manoël, et al.
Publicado: (2017)

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018)

Potent Dual Inhibitors of TORC1 and TORC2 Complexes (KU-0063794 and KU-0068650) Demonstrate In Vitro and Ex Vivo Anti-Keloid Scar Activity
por: Syed, Farhatullah, et al.
Publicado: (2013)

Targeted Molecular Therapy in Glioblastoma
por: Festuccia, Claudio, et al.
Publicado: (2020)

Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
por: Chen, Long, et al.
Publicado: (2015)

Redesigning TOR Kinase to Explore the Structural Basis for TORC1 and TORC2 Assembly
por: Hill, Andrew, et al.
Publicado: (2018)

The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling
por: Merhi, Ahmad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lsci1rm7vdge3dphi31eoeqg98